focus -WSS

focus

author：leisure time 2025-09-28 18:31:15 - browse：3

Eli Lilly headquarters in Indianapolis – pharmaceutical coverage from STAT — Darron Cummings/AP

LONDON — A U.K. government agency on Tuesday said that it won’t recommend Eli Lilly’s Mounjaro — part of a new class of medications that help patients lose weight — for people with type 2 diabetes without additional evidence.

Mounjaro, also known as tirzepatide, has U.S. approval for type 2 diabetes and is expected to win the regulatory green light for obesity later this year. It is one of several medications, along with Wegovy and Ozempic from Novo Nordisk, that have shown dramatic weight loss results, creating a surge in demand and blockbuster sales expectations.

But in draft guidance, the U.K.’s National Institute for Health and Care Excellence, which assesses the cost-effectiveness of medications, said it had asked Lilly for more data “to address the uncertainties in the clinical evidence, when compared to all relevant alternative treatments.” NICE recommendations are used by the National Health Service to determine whether to provide certain medications.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： Judge in Trump's Jan. 6 case gives attorneys 2 weeks to propose trial date

WSS

Shionogi licenses Pompe disease therapy from Maze Therapeutics

Flash flooding emergencies prompt evacuations in Kentucky, Tennessee

Readout Newsletter: Sanofi, Novavax, Maze x Shionogi news

Medicare says breakthrough device reimbursement rule to come by summer

Steward Health Care files for bankruptcy

Calls for Trump's election interference trial to be televised part of long debate

explore

focus

Wikipedia

In Memoriam: Notable people who died in 2023

What to know about 'Guardians of the Galaxy Vol. 3' as it hits Disney+

Heart attack and stroke risk calculators need revising

What to know about 'Guardians of the Galaxy Vol. 3' as it hits Disney+

State Dept. review finds Biden bears some blame for Afghanistan failures

Does Medicare's free annual wellness visit do any good?

Virginia high school admissions case could be legal follow

Jailed Russian opposition leader Alexey Navalny gets 19 more years in prison

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

First recipient of genetically engineered pig kidney has died

hotspot

Alcohol isn't healthy after all. Will new dietary guidelines reflect that?

Rock icon Freddie Mercury pre

Sanofi strikes deal with Novavax, boosting the vaccine maker

CDC wastewater surveillance dashboard to track bird flu hotspots

Apple Watch's A

Sanofi strikes deal with Novavax, boosting the vaccine maker

focus

explore

entertainment

entertainment